CEO of Amylyx Trades 7,715 Shares in Tax‑Triggered Sale: What It Means for the ALS‑Drug Company?
Insightful look at Amylyx CEO insider sales, tax‑triggers, and what they mean for investors amid ALS drug development uncertainty.
3 minutes to read
Amylyx Pharmaceuticals Inc